Antisense RNA, which has a sequence complementary to mRNA, may provide the basis for antiviral therapies of high selectivity. We have explored the inhibitory effect of six antisense RNAs upon the replication of human immunodeficiency virus (HIV) in cell culture. We chose regions of the HIV genome to test whether sequences required for splicing or for translation initiation were more susceptible to antisense RNA interference. Our results suggest that inhibitory antisense RNAs contain sequences complementary to the AUG initiation codon of the tat gene and have a comparatively low tendency to form intramolecular base pairs which would interfere with intermolecular duplex formation. Inhibition can be substantial (over 70%) but is transient. Transience does not result from mutation of the input virus. Inhibition was not a consequence of the induction of interferon by antisense RNA-mRNA duplex formation. Our results suggest that at least part of the inhibitory effect is at the posttranscriptional level.
Introduction
Regulation of gene expression by antisense RNA occurs naturally in prokaryotes (Simons & Kleckner, 1988) and eukaryotes (Gordon et al., 1988; Khochbin & Lawrence, 1989; Kimelman & Kirschner, 1989; Volk et al., 1989) . It has been used experimentally to modulate gene activity in vivo in plants (Rodermel et al., 1988 , Rogers, 1988 Smith et al., 1988 ; Cuozzo et al., 1988 ; Hemenway et al., 1988) and animals (Giebelhaus et al., 1988) . The mechanism of inhibition may include interference with RNA processing or inhibition of the initiation of translation (Munroe, 1988; Walder, 1988; Cotten et al., 1989) . For this reason, there is a possibility that one could exploit antisense nucleic acid to inhibit the replication of viruses m vivo without affecting the expression of host genes. HIV is a good system for investigating this approach because it is a pathogen of great and growing significance, it is relatively well characterized at the molecular level, and it is not as yet amenable to immunoprophylaxis or curative chemotherapy.
There are two major methods of introducing antisense nucleic acid into cells. Firstly, one can bathe susceptible cells in preformed oligonucleotides (Zamecnik et al., 1986; Matsukura et al., 1987; Agrawal et al., 1988; Goodchild et al., 1988; Sarin et al., 1988; Zaia et al., 1988; Shibahara et al., 1989) . Although oligonucleotides have proved to be reasonably effective against HIV, they ~-Present address: Xenova Ltd, Slough SL1 4EQ, U.K. appear to exert their effects in a largely sequence nonspecific manner and to be variably cytotoxic. Alternatively, one can introduce a gene into susceptible cells which is transcribed to produce antisense RNA. This approach has been used for other viruses (Chang & Stoltzfus, 1987; von Ruden & Gilboa, 1989; Cuozzo et al., 1988; Hemenway et al., 1988) . We chose to use retroviral vectors rather than transfection to introduce the antisense genes into cells since we find that transfected cells frequently show abnormalities in their cell surface markers, rates of growth and susceptibilty to HIV. In this paper we report that some antisense RNAs can substantially inhibit HIV replication, albeit transiently, when expressed from a provirus. We investigate the features of an antisense RNA which determine its inhibitory potential, whether it induces interferon, the effect it has on HIV mRNA levels and the reasons for the transience of inhibition.
Introduction of antisense RNA-encoding proviruses into HIV-susceptible cells.
Psi-2 cells were transfected with the retroviral constructs by calcium phosphate coprecipitation (Brown et al., 1987) , and the transfectants were selected using G418 (800gg/ml; Gibco). PA317 cells were transduced with the ecotropic retrovirus-containing supernatants of the transfected Psi-2 cells (Brown et al., 1987) . G418-resistant transduced PA317 cell lines were cloned and analysed individually for high level production of amphotropic G418-resistant colony-forming units. Jurkat cells (4 x 105) were exposed to 6x 10 s c.f.u, of amphotropic retrovirus for 24 h, after which G418 (800 gg/ml) was added. The resistant ceils grew to a density of 105 cells/ml after 10 to 14 days, suggesting that the transduced cultures contained approximately 104 clones of transduced cells. The name of each transduced cell line is derived from the parental cell and the antisense gene. Jurkat. AR0 was transduced with the retroviral vector alone.
Analysis of surface-expressed CD4 using flow cytometry. One-million cells were resuspended in PBS/BSA [Dulbecco's phosphate-buffered saline with calcium or magnesium, supplemented with bovine serum albumin (1%, w/v)] containing the monoclonal antibody, MT15I (anti-CD4; 5 ~tg/ml; code no. 508 in McMichael, 1987) or OX21 (negative control; 5 gg/ml) and incubated at 4 °C for 2 h. The cells were washed twice in PBS/BSA, then resuspended in fluorescein isothiocyanateconjugated, rabbit anti-mouse Ig (200 lag/ml, 50 gl) and incubated for 1 h at 4 °C. The cells were diluted to 1 ml with PBS/BSA and analysed in a Becton-Dickinson FACSCAN.
Detection of sense and antisense RNA in cells. Total cellular RNA was prepared and analysed by Northern blotting as described by Ausubel et al. (1987) . GeneScreen-Plus (DuPont) was used as the transfer membrane. Two plasmids were constructed for the synthesis of riboprobes: the first, pSPTI9.AR2, was constructed by cloning the EcoRI (5325)-Kpnl (5926) fragment of pBH10 (see above) into the transcription vector, pSPTI9 (Pharmacia); the second, pSPT19.NeoSV, was constructed by cloning the KpnI (365)-Saci(3615) fragment of the retroviral vector, IRV.Neo.SV, into pSPT19. Both were transcribed with SP6 polymerase and [3:p]CTP (Ausubel et al., 1987) to generate radiolabelled probes that hybridized to antisense RNA derived from sequences within the AR2 region of HIV (see above), or to all RNAs transcribed from the retroviral vector, respectively. Hybridization was done using 10 s c.p.m./ml of riboprobe in a sealed plastic bag at 60 °C overnight. The hybridization solution contained 50~ formamide, 1% SDS, 5 x SSC, 8 x Denhardt's solution, 250 gg/ml sheared salmon sperm DNA and 300 gg/ml yeast RNA. The filter was washed twice in 2 x SSC at room temperature, once in 2 × SSC, 1% SDS (30 min, 65 °C), and then exposed to X-ray film (Kodak X-omat S) overnight at -70 °C.
Growth and detection of HIV. The TCIDs0 of HIV stocks was determined in Jurkat cells. The growth of HIV was measured using the DuPont p24 core antigen ELISA kit. Jurkat cells and their derivatives were infected with HIV at an m.o.i, of 0.01 and incubated overnight. Input virus was removed by washing the cells in growth medium 16 h post-infection (p.i.). Cell-free samples of culture supernatant (0.5 ml) were taken at intervals and stored at -85 °C. Since we had observed that the rate of HIV replication in Jurkat cells depended upon the growth rate of the cells, we ensured that, in any comparison between transduced Jurkat cells, all cells were growing at the same, exponential rate during the 3 days preceding challenge with HIV.
Prediction of RNA secondary structure. The predicted pattern of folding of antisense RNAs was generated using the FOLD-VAX RNA secondary structure prediction program of Michael Zuker, VAX/VMS version, 1986 . We used Turner's energy rules (Freier et al., 1986) which are optimized for 37 °C and have been adjusted in the light of experimental observations (see Zuker, 1989) . The predicted structures were substantially similar when Salser's energy rules were used (Salser, 1978) . The prediction of the secondary structure of HIV mRNA in the region discussed in the text was done on the 1121 nucleotides beginning at nucleotide position 5000 relative to the start of transcription. The secondary structure predictions of each of the antisense RNAs was done on the antisense RNA and 225 bases of vector sequence flanking it to the 3' and 5' ends. The total length of RNA folded in each case was: AR2, 1067 bases; AR5, 569 bases; AR6, 502 bases; AR9, 626 bases; ARI0, 608 bases; ARI 1,474 bases. None of the values or structures referred to in the text were substantially altered by including 50 bases more or less in the flanking regions for computer analysis.
Detection of interferon in cell culture supernatants. We used an assay that depended upon the reduction of Cocal virus plaque numbers in HeLa cells preincubated with interferon-containing medium. HeLa cells (2.5 x 105) were added to each well of a 24-well plate (Costar). Samples (0.5 ml) of the culture supernatant to be tested were added to each well and the plate was incubated at 37 °C, 5~ CO2 for 24 h. Cocal virus (50 or 500 p.f.u, in 0.1 ml) was added to each well under test and incubated at 37 °C for 30 min. A semi-solid overlay consisting of growth medium containing 1-5 % carboxymethyl cellulose (0-5 ml) was added to each well and the plate was incubated for 1 to 2 days at 37 °C, 5~ CO2. The plate was then washed with normal saline and stained using amido black. A reduction in the apparent titre of Cocal virus indicated the presence of interferon. A standard preparation of natural, human c~-interferon (Wellferon, a generous gift of the Wellcome Foundation) was used to establish the sensitivity of the assay. In our hands, one unit of Wellferon produced a 50% reduction in plaque numbers, in agreement with the suppliers' assay.
Results

Construction of antisense genes and their transfer into Jurkat cells
We constructed antisense RNA-encoding genes aimed at two regions of HIV transcripts. Within the central region of the HIV genome, these correspond to the tat, rev and vpu splice acceptor sites, the tat/rev splice donor site and the initiation codons for translation of tat, rev, vpu and env proteins ( Fig. 1 b and Methods). The antisense gene AR9 corresponds to an RNA sequence in the 5' non-coding region common to all HIV mRNAs ( Fig. 1 c and Methods). These constructs were designed not only to identify effective antisense genes but also to shed some light on the mechanism of antisense RNA action.
We transduced Jurkat cells with the antisense genes using a retrovirus vector. The polyclonal nature of the transduced lines ensured that observed differences between antisense genes would not depend upon the site of integration of retrovirus in particular transduced clones. Since we had observed that Jurkat cells occasionally lost CD4 expression during culture, we checked that the levels of surface expression of CD4 were comparable in each cell line using flow cytometry (results not shown).
To check that the transduced cells were producing antisense RNA, we probed total cellular RNA prepared from each Jurkat cell line with strand-specific RNA (Fig. 2) . The relative abundance of antisense RNAs transcribed from the vectors can be determined from the autoradiogram (Fig. 2a) , since the probe used hybridizes to a sequence common to all of the RNAs transcribed from the retroviral vector. The values, relative to that transcribed from the vector alone, are: AR2, 1.47; AR5, 1.66; AR6, 1.52; AR9, 3.66; AR10, 0.54; ARll, 1.22. Fig. 2 (b) shows a similar blot probed with an AR2 antisense RNA-specific probe. As expected, no hybridization is detected to RNA transcribed from the vector alone nor from the vector containing AR9, which was derived from the HIV long terminal repeat (LTR). The relative intensities of these bands are affected by the length of the complementarity between the probe and the antisense RNA.
The effect of antisense R N A upon H I V replication
It was possible that the retroviral vectorper se might alter the rate of HI¥ replication in transduced Jurkat cells. The polyclonal line of Jurkat cells carrying the vector sequence alone (Jurkat.AR0) grew at the same rate in medium containing G418 as did the parental Jurkat cells grown in G418-free medium (results not shown). We challenged both Jurkat.AR0 and control Jurkat cells with HIV and measured the production of HIV in each case (Fig. 3 a) . The results show that the retroviral vector per se does not affect the replication rate of HIV. We challenged the antisense RNA-transduced cells with HIV and then monitored the replication of HIV by assaying for the core antigen, p24 (Fig. 3b) . Our results show that the replication of HIV in Jurkat cells can be inhibited by endogenously synthesized antisense RNA. Only two of our antisense constructs (AR2 and AR6) give consistently high levels of inhibition of HIV. The other antisense genes give negligible inhibition. There was no correlation between the abundance of the antisense RNA in the cell and the degree of inhibition.
Secondary structure predictions
The differences observed in the inhibitory potential of each antisense RNA might result from their relative tendency to form intramolecular base pairs that would preclude hybridization to HIV transcripts. Accordingly, we used the Fold-Vax program (Zuker, 1989) to predict the secondary structure adopted by the HIV primary transcript in the region of the antisense RNAs (Fig. 4) . One measure of the tendency of each antisense RNA to form intramolecular base pairs is the predicted change in free energy per nucleotide resulting from folding. The least tightly folded is AR2, -1-00 kJ/mmol, followed by AR6 (-1-05), ARll (-1.05), AR10 (-1.09), AR9 (-1.09) and AR5 (-1.13). These results suggest that AR5 might be non-inhibitory because it is tightly folded. However if this were the whole explanation, one would expect AR11 to be inhibitory. Two reasonable explanations for this are that the target of AR11 (the splice acceptor site at the 5' end of tat exon 2) is not susceptible to antisense inhibition, or that the length of the antisense-sense RNA duplex formed by AR11 (43 bp) is not sufficiently stable to be inhibitory. These possibilities cannot be distinguished by our results. One might have expected that the local secondary structure in the region of a particular feature such as an anti-initiation codon would have been important. However this does not seem to be the case. For example, the predicted secondary structure in the region around the anti-tat initiation codon is identical in AR5 and AR6 (Fig. 4) . Inhibitory antisense RNAs, AR2 and AR6, have a combination of two properties not found in the non-inhibitory antisense RNAs: they have only a low tendency to form intramolecular base pairs and they possess a region complementary to the tat initiation codon.
Transcription of HIV after infection of antisense RNAtransduced cells.
To investigate whether antisense RNA inhibition intervenes before or after the formation of spliced HIV Fig. 5) . The antisense gene AR2 gives an approximately 50~ reduction in all three HIV mRNA species. The abundance of the HIV mRNAs was not substantially altered in any of the other transduced cells. Since, of the two inhibitory antisense genes, AR2 produces a significant reduction in HIV mRNA levels and AR6 does not, it is tempting to conclude that the inhibition caused by AR6 occurs at the translational level whereas that by AR2 is partly caused by a reduction in the production of HIV mRNAs. . We developed an assay that was capable of detecting less than 1 unit of a-interferon per ml (see Methods). We assayed culture supernatants from Jurkat cells expressing each antisense RNA 7 days following challenge with HIV in an experiment similar to that described above. In no culture was interferon activity detected (results not shown).
Is antisense inhibition the result of interferon induction ?
It
The transience of antisense RNA inhibition
The greatest degree of inhibition occurs about 1 week p.i. (Fig. 3 b) after which there appears to be a significant and reproducible, though incomplete, escape from inhibition. One explanation for these results is that escape from inhibition represents the outgrowth of sequence variants of HIV which would be at a selective advantage because antisense RNA would not bind to their transcripts. If the emergence of antisense-escape mutants accounted fully for the transience of inhibition, one would then expect that the virus, harvested from a culture of antisense RNA-expressing cells in the second week following challenge with HIV, would be largely resistant to , and used this in a challenge experiment• In this experiment, the virus was still inhibited by both AR2 and AR6. The degree of inhibition was slightly less than that shown in Fig. 3 (b) and the escape from inhibition was slightly advanced. These small differences, however, are not sufficient to explain the degree of escape observed in the previous experiment and might be due to the higher dose (approximately twofold) of input virus used in the latter experiment• Consequently, we believe that the reason for escape from antisense RNA inhibition is not mutational but regulatory; that is, it lies in the relative strengths of the regulatory elements governing transcription of the antisense and H]V RNAs. Whereas the antisense RNAs are expressed at a relatively constant level, transcription of HIV rises from an initially low level on entry into the cell to a much higher level once tat is expressed. One explanation is that the relatively constant amount of antisense RNA, transcribed from the retroviral vector, is sufficient to inactivate most of the RNA transcribed from the non-activated HIV LTR but is insufficient to match the transcripts from the tat-activated LTR. Any HIV tat mRNA that escapes antisense inhibition at the early stage will be translated to produce tat which in turn will stimulate the production of greater quantities of tat mRNA. There are additional mechanisms whereby escape of HIV from antisense inhibition in one cell in the population might induce HIV replication in neighbouring cells. Unconfirmed reports suggest that tat can be released from HIV-infected cells and it is known that tat can be taken up by nearby cells resulting in transactivation of resident HIV proviruses (Frankel & Pabo, 1988) and that tat can induce increased expression of CD4 (Koka et al., 1988 ) which may in turn increase virus production. This means that even if one HIV-infected cell were to escape from antisense RNA inhibition, the effect would spread to the rest of the population.
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Discussion
It is somewhat difficult to compare our results with those of other workers using different viruses. In the most comparable case, using an antisense RNA-encoding retrovirus against human T cell lymphoma-leukaemia virus type I (von Ruden & Gilboa, 1989) , the effect of the virus on the proliferation of T cells rather than on the production of virus itself was measured. In another study in which a 10-fold molar excess of antisense RNAencoding plasmid was cotransfected with Rous sarcoma proviral clones (Chang & Stoltzfus, 1987) , levels of inhibition of the production of infectious virus were between 23% and 82% depending on the construct. In our system, there is likely to be one copy of the antisense gene per cell. Cases in which absolute abolition of gene expression have been noted involve the introduction of a large excess of the antisense gene into the cell (e.g. about 10 v microinjected copies per cell; Giebelhaus et al., 1988) . However, in one case a 1000-fold excess of antisense RNA failed to inhibit the translation of chloramphenicol acetyltransferase mRNA (Kerr et al., 1988) . Judging from a number of positive results which have appeared in the literature, the levels of inhibition that we have demonstrated seem to be within the range that one would expect from an unmodified antisense system (Izant & Weintraub, 1984; Crowley et al., 1985; Kim & Wold, 1985; McGarry & Lindquist, 1986; SandriGoldin et al., 1987; Jennings & Molloy, 1987; Hambor et aL, 1988) . Can one conclude anything from our results concerning the mechanism of antisense RNA inhibition that would help one to design inhibitory antisense genes ? Our results suggest that an antisense RNA must not have a strong tendency to fold upon itself; otherwise it cannot hybridize to the target RNA. The prediction of RNA secondary structure is not perfect although we have taken a number of precautions to maximize its reliability. In addition, it appears that initiation codons of regulatory genes are particularly good targets for antisense inhibition and our results are consistent with translational arrest being a component of the inhibitory mechanism. Finally we have shown that the induction of interferon by antisense-sense RNA duplexes is not the mechanism of inhibition.
A number of complementary approaches might be taken to increase the effectiveness of antisense RNA inhibition. One might seek further to attenuate the residual level of target mRNA translation so that the breakthrough concentration of tat is never attained. This might be achieved by employing stronger expression vectors or by developing vectors which could provide coordinately regulated synthesis of antisense RNA to counteract any rise in target mRNA expression. Secondly one might develop more effective antisense genes, and in the process test our proposals for the requirements of inhibitory antisense genes, outlined above. Finally one might attempt to produce antisense ribozyme genes by incorporation of catalytic sequences into the inhibitory antisense genes.
